enGene

Read more
Jason D. Hanson's photo - President & CEO of enGene

President & CEO

Jason D. Hanson

CEO Approval Rating

90/100

Founded:

1999

Status:

PrivateIndependent Company

Est. Annual Revenue
$3.5M
Agree?
Est. Employees
58
Agree?

ENGENE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

enGene's company profile
Jason D. Hanson's photo - President & CEO of enGene

Jason D. Hanson

President & CEO

90/100
58
$0
$3.5M
View Profile
1
enGene's Competitor - Synthego logo
Paul Dabrowski's photo - Co-Founder & CEO of Synthego

Paul Dabrowski

Co-Founder & CEO

89/100
250
$259.7M
$13M
View Profile
2
enGene's Competitor - Beam logo
John Evans's photo - CEO of Beam

John Evans

CEO

90/100
182
$689M
$ < 1M
View Profile
3
enGene's Competitor - CRISPR logo
Samarth Kulkarni's photo - CEO of CRISPR

Samarth Kulkarni

CEO

97/100
410
$183M
$901.8M
View Profile

Missing a competitor? Contribute!

Synthego is perceived as one of enGene's biggest rivals. Synthego was founded in 2011 in Menlo Park, California. Synthego is in the Biotechnology field. Synthego generates $9.5M more revenue than enGene.

Beam is enGene's #2 rival. Beam is a Public company that was founded in 2017 in Cambridge, Massachusetts. Beam competes in the Biotechnology field. Compared to enGene, Beam has 124 more employees.

CRISPR is one of enGene's top competitors. CRISPR's headquarters is in Zug, Zug, and was founded in 2013. Like enGene, CRISPR also operates in the Biotechnology industry. CRISPR generates 25,764% of enGene's revenue.

enGene Acquisitions

No recent acquisitions found related to enGene

enGene Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Since enGene was founded in 1999, it has participated in 1 round of funding. In total enGene has raised $0. enGene's funding round was on Oct 2020 for a total of $0

enGene Investments

No recent investments found related to enGene

enGene News

enGene Press Releases

October 29, 2020Cision Canada

enGene Receives Funding Through Cystic Fibrosis Foundation's Path to a Cure for the Discovery of Novel Gene Therapies to Treat Cystic Fibrosis

/CNW/ - enGene Inc., a biotechnology company developing non-viral gene therapies for local administra... See more »

Social Media

enGene Headquarters

201 Jones Road ‍

Waltham, Massachusetts02416

Driving Directions »

Trending Companies

enGene Summary

ABOUT

Overview

enGene develops a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. enGene was founded in 1999. enGene's headquarters is located in Waltham, Massachusetts, USA 02416. enGene's President & ...

CEO

enGene's President & CEO, Jason D. Hanson, currently has an approval rating of 90%. enGene's primary competitors are Synthego, Beam & CRISPR.

Website

engene.com

Frequently Asked Questions about enGene

  1. When was enGene founded?

    enGene was founded in 1999
  2. Who is enGene's CEO?

    enGene's CEO is Jason D. Hanson
  3. How much revenue does enGene generate?

    enGene generates $3.5M in revenue
  4. How much funding does enGene have?

    enGene has historically raised $0 in funding
  1. Where is enGene's headquarters?

    enGene's headquarters is in Waltham Massachusetts, USA
  2. How many employees does enGene have?

    enGene has 58 employees
  3. What sector does enGene operate in?

    enGene is in Biotechnology
  4. Who are enGene's competitors?

    enGene's top competitors are Synthego, Beam, CRISPR